BioAge Labs Ratios (2024-2025) | BIOA

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter) -219.02%-478.57%-496.30%-504.84%
EBT Margin (Quarter) -895.04%-893.53%-979.99%-835.71%
EBIT Margin (Quarter) -1,133.43%-1,026.99%-1,126.58%-923.42%
EBITDA Margin (Quarter) -889.66%-896.14%-978.97%-842.76%
Operating Margin (Quarter) -1,133.43%-1,026.99%-1,126.58%-923.42%
Net Margin (Quarter) -895.04%-893.53%-979.99%-835.71%
FCF Margin (Quarter) -1,225.98%-834.49%-782.18%-921.47%
Efficiency
Assets Average (Quarter) 347.81M351.04M332.99M313.62M299.99M
Equity Average (Quarter) -191.32M58.31M318.44M318.15M303.97M286.12M274.76M
Invested Capital (Quarter) -185.51M-197.13M319.75M329.13M319.17M299.78M280.96M274.05M
Asset Utilization Ratio (Quarter) 0.000.010.020.03
Leverage & Solvency
Interest Coverage Ratio (Quarter) -10.53-34.47-63.79-79.50-64.49-123.24-155.30-308.95
Debt to Equity (Quarter) 0.030.030.020.020.010.01
Debt Ratio (Quarter) 0.030.020.020.020.010.01
Equity Ratio (Quarter) 0.930.900.910.920.910.92
Times Interest Earned (Quarter) -10.53-34.47-63.79-79.50-64.49-123.24-155.30-308.95
Valuation
Enterprise Value (Quarter) -173.99M-334.50M-354.35M-320.23M-297.01M-285.78M-281.10M
Return Ratios
Return on Sales (Quarter) -8.95%-8.94%-9.80%-8.36%
Return on Capital Employed (Quarter) -0.24%-0.25%-0.29%-0.31%-0.33%
Return on Assets (Quarter) -0.20%-0.20%-0.24%-0.24%-0.27%
Return on Equity (Quarter) -0.22%-0.22%-0.26%-0.27%-0.29%